Blog: We must do better…

June 11, 2020 | Todd Kuiken

Todd Kuiken, June 11, 2020 | The following reflection was part of a special GES colloquium held on June 5, 2020, discussing the new USDA regulations on GM crops. Which was held in the midst of national protests against police brutality. They are my personal reflections in support of #blacklivesmatter and the systemic racism and inequalities seen throughout our institutions....

Continue reading "Blog: We must do better…"

Genetically modified mosquitoes could be released in Florida and Texas beginning this summer – silver bullet or jumping the gun?

June 3, 2020 | Jennifer Kuzma

Jennifer Kuzma, June 3, 2020 | Release of GM mosquitoes in Florida is imminent. But a multidisciplinary team of scientists believe that more studies are needed first. They encourage a publicly accessible registry for GM organisms....

Continue reading "Genetically modified mosquitoes could be released in Florida and Texas beginning this summer – silver bullet or jumping the gun?"

Blog: COVID-19 Reveals the Personal Side of Globalization – GM Researchers Should Take Note

May 20, 2020 | Nora Haenn

Nora Haenn, 5/20/2020 | COVID-19 has shown us, there’s an important consequence for the way globalization is both local at all points and persistently invisible in its entirety....

Continue reading "Blog: COVID-19 Reveals the Personal Side of Globalization – GM Researchers Should Take Note"

Blog: Yes, and…

April 22, 2020 | Guest Author

Royden Saah and Eli Hornstein, 4/22/2020 | To counter the COVID-19 pandemic, YES we can be responsible AND take urgent, unfamiliar action....

Continue reading "Blog: Yes, and…"

Image of a healthcare worker behind a decision-tree of Coronavirus-related icons

COVID-19—Biotechnology Is Never Enough

April 3, 2020 | Jennifer Kuzma

The currently-unfolding COVID-19 case boldly underscores the reality that science and technology are never enough to solve global health problems alone. Rather, we need a strategic and systematic integration of social sciences, risk sciences, and communication along with science, technology, and innovation to adequately meet the challenges of emerging global risks, such as COVID-19. ...

Continue reading "COVID-19—Biotechnology Is Never Enough"

Lessons Learned for Risk Governance of Synthetic Biology, Nanomaterials, and Other Emerging Technologies in a Post-2020 World

December 13, 2019 | Todd Kuiken

Khara Grieger and Todd Kuiken, Dec. 13, 2019 | On December 9th, a symposium was held at the 2019 Annual Meeting of the Society for Risk Analysis, entitled “Risk Analysis of Engineered Nanomaterials: Where Have We Been, Lessons Learned, and Transfer of Knowledge to Other Emerging Technologies,” as a part of the Advanced Materials and Technologies Specialty Group....

Continue reading "Lessons Learned for Risk Governance of Synthetic Biology, Nanomaterials, and Other Emerging Technologies in a Post-2020 World"

Does the US public support using gene drives to control agricultural pests?

September 11, 2019 | Guest Author

Mike Jones, Sep. 11, 2019 | The development of gene drives is progressing more rapidly than our understanding of public values towards these technologies. Findings from this research can inform responsible innovation in gene drive development and risk assessment....

Continue reading "Does the US public support using gene drives to control agricultural pests?"

Photo of Khara Grieger

Faculty Spotlight: Khara Grieger

July 15, 2019 | Patti Mulligan

Patti Mulligan, July 15, 2019 | INTERVIEW: We sat down with the GES Center's newest Senior Research Scholar, Khara Grieger. She joined our team in the spring of 2019, but has already given a colloquium and is working on several nanotechnology-related research projects....

Continue reading "Faculty Spotlight: Khara Grieger"

Figure 1 Summary of GE Plants Oversight in Proposed Rule - J. Kuzma

Biotechnology Oversight Gets an Early Make-Over by Trump’s White House and USDA: Part 2 – The USDA-APHIS Rule

July 2, 2019 | Jennifer Kuzma

Jennifer Kuzma, July 2, 2019 | USDA-APHIS has proposed an oversight process for GE crops that appears to be a significant departure from the current one. This article discusses the features of the proposed new rule, along with its strengths and weaknesses and my recommendations for how it should be amended. ...

Continue reading "Biotechnology Oversight Gets an Early Make-Over by Trump’s White House and USDA: Part 2 – The USDA-APHIS Rule"

Word cloud created from the language in the Regulation of Ag Biotech Executive Order

Biotechnology Oversight Gets an Early Make-Over by Trump’s White House and USDA: Part 1—The Executive Order

June 18, 2019 | Jennifer Kuzma

Jennifer Kuzma, June 18, 2019 | Last week, the Trump administration set the tone for its oversight of agricultural biotechnology (ag biotech) through two major actions: 1) Signing the Modernizing the Regulatory Framework for Agricultural Biotechnology Products Executive Order; and 2) Proposing a draft rule on the Movement of Certain Genetically Engineered Organisms (GEOs), changing how USDA reviews GE plants....

Continue reading "Biotechnology Oversight Gets an Early Make-Over by Trump’s White House and USDA: Part 1—The Executive Order"